carotid plaque surface (smooth, irregular, ulcerated), NIHSS group score before surgery (0 or TIA, 1-3, 4-6, Ն7) and presence of ischemic lesions at preoperative CT scans for analysis. Significance threshold was set at PϽ.05.
Objectives:
To identify risk factors compromising 3 years survival in treated patients with asymptomatic carotid disease in complying with recently updated guidelines from the Society for Vascular Surgery.
Methods: Outcomes of 504 patients who underwent carotid intervention for asymptomatic carotid disease in 10 years (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) were analyzed. Hospital computerized medical records were reviewed. Social Security Death Index was queried for mortality. Patients lost to follow up before 3 years post procedure were excluded. After multivariable Cox regression analysis was done, a score was assigned for each risk factor (RF): hazard ratio (HR) 1.5-2.0 ϭ RF 1; HR 2.1-3.0 ϭ RF 2; HR 3.1-4.0 ϭ RF 3. Then a Kaplan Meier plot analyzed survival differences.
Results: Fifteen percent of the patients did not survive beyond 3 years post procedure. Age Ͼ 80 years (HR 2.0, P ϭ .01, RF ϭ 1), Chronic obstructive pulmonary disease (HR 3.6, P ϭ .001, RF ϭ 3), Chronic kidney disease (CKD) stage 3 (HR 2.0 P ϭ .07, RF ϭ 1), CKD stage 4 (HR 3.3, P ϭ .04, RF ϭ 3), Coronary artery disease (HR 2.46, P ϭ .001, RF ϭ 2) and Diabetes Mellitus (HR 1.8, P ϭ .02, RF ϭ 1) negatively influenced 3 year survival.
Thirty days mortality rate was 0.9% and was not influenced by score values; however, a cumulative score Ͻ 3 was associated with 3 year survival of 93%.
Conclusions: Despite low 30 day mortality rate, increasing risk factors are associated with decreased 3 year survival. This finding may impact clinical decision for management of asymptomatic carotid disease. The University of Texas at San Antonio, San Antonio, TX Objectives: To review retrospectively records of patients treated with carotid artery stenting (CAS) to investigate correlations between clinical variables, distal protection filter (DPF) characteristics, and 30-day peri/post-procedural outcomes.
Methods: This is a multicenter, single-arm study of DPF-protected CAS in the Pittsburgh region between 2000 and 2011. Analysis of peri/post-procedure complications included myocardial infarction (MI), transient ischemic attacks (TIA), stroke, death, and a composite of all adverse events (AE). Characteristics for the DPFs were previously determined in vitro and were used to find correlations with CAS outcomes. Univariate, multivariate, and goodness-of-fit analyses were performed.
Results: 731 CAS procedures employing six different DPF were analyzed. Peri/post-procedural AE included 19 TIAs (2.6%), 38 strokes (5.2%), 1 MI (.1%), 19 deaths (3.6%) and a total of 61 patients with complications (8.3%). Univariate analysis for filter design characteristics showed that the composite of AE was negatively associated with both vascular resistance (P ϭ .01) and eccentricity (P ϭ .02), and positively associated with porosity (P ϭ .0007), number of pores (P ϭ .005), and pore density (P ϭ .001). Multivariate analysis and the goodness-of-fit test revealed that history of congestive heart failure (CHF), stroke, and TIA (each with OR Ͼ1) led to a good-fit model P value of .72 for peri/post-procedural AE. Multivariate analysis was inconclusive for all filter design characteristics.
Conclusions: The following filter design characteristics are independently significant for lower peri/post-procedural AEs: higher vascular resistance, concentric in shape, greater capture efficiency, lower porosity, lower number of pores and lower pore density. This information can be used when considering the desirable design characteristics of future DPFs, but our data also demonstrate that the patient's clinical features have overriding importance as predictors of AEs.
Author Disclosures: R. Chaer: Nothing to disclose; E. A. Finol: Nothing to disclose; N. Loghmanpour: Nothing to disclose; S. Muluk: Nothing to disclose; G. Siewiorek: Nothing to disclose; K. Wanamaker: Nothing to disclose; M. Wholey: Cordis, Consulting fees or other remuneration (payment)Abbott, Consulting fees or other remuneration (payment)Boston Scientific, Consulting fees or other remuneration (payment). Objectives: Gender differences in the presentation of patients undergoing CEA and CAS are not well studied. Women have been shown to benefit less from revascularization for asymptomatic carotid disease. Therefore, we analyzed a regional database to identify gender differences in patient presentation for CEA and CAS.
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Gender Differences in Presentation of
Methods: We used the Vascular Study Group of New England database to identify all patients undergoing CEA or CAS. We analyzed demographics, comorbidities, symptom status, and outcomes in men and women.
Results: We identified 9376 patients: 8852 CEA and 524 CAS. Men comprised 60% of the study group. Mean age was similar at 69 years. Women were more likely to be current smokers with COPD and had less heart disease and prior CABG/PCI. For CEA women were more likely to be asymptomatic than men (70% vs 65%; PϽ.001). Of asymptomatic patients, a similar proportion had carotid stenoses Ͼ80% (74.3% in women vs 72.5% in men; P ϭ .11). Both symptomatic and asymptomatic women had similar rates of any stroke or death compared to men (symptomatic 2.2% vs 2.1%; P ϭ .81 and asymptomatic 0.9% vs 0.9%; P ϭ .76).
Conclusions:
Despite prior data suggesting women benefit less from carotid revascularization for asymptomatic carotid disease, 70% of revascularizations were performed in asymptomatic women. Stroke and death rates compare favorably to randomized controlled trials for both symptomatic and asymptomatic patients. 
